Founded in 2005, the Company designs, manufactures, and sells patented transdermal metered dosing dispensers/applicators. The Company’s trademarked dispensers provide easy-to-use built-in applicators that eliminate transference issues with hands and assures correct dosing. The combination of audible, visual, and tactile clicks makes it easy for patients to accurately dose medications. Products are registered FDA devices, Class I Dispensers, made of all FDA approved materials and intended for single use only. Customers include compounding pharmacies, specialty pharmacies, hospital pharmacies, community pharmacies and medical offices. Current customer market segments include hormone replacement therapy (80%), pain relief and scar therapy (10%), and veterinary medicine (10%). 95% of revenue comes from recurring active customer and distributor orders. The owners are seeking a partner to help take the business to the next level, and liquidity for future retirement purposes. • Superior Name and Reputation: The Company has a strong reputation for its focus on service, offering proprietary products and design-support expertise, as well as providing one of the most precise topical metered dosing solutions in the industry. • High Customer Retention Rate: Due to Company’s reputation, long-term presence in the industry, and broad in-house capabilities, the Company’s recurring account retention rate exceeds 95%. • Qualifications: The Company’s structure, patented products, expertise with compounding pharmacies, active new product introduction processes, and integrated management systems are designed to provide clients with interdisciplinary solutions. • Focus on Innovation: The Company consistently focuses on innovation and customer-driven solutions. The Company is well-regarded for its responsiveness to customer needs, which has resulted in customers turning to them with new ongoing opportunities. • Increased Drug Therapy Use: As overall health care costs continue to rise, governments and private payers are encouraging the use of drug therapies to reduce costs.